Mink therapeutics announces virtual annual shareholders meeting

New york, june 05, 2023 (globe newswire) -- mink therapeutics (nasdaq: inkt), a clinical-stage biopharmaceutical company specializing in the discovery, development, and commercialization of allogeneic, off-the-shelf, invariant natural killer t (inkt) cell therapies to treat cancer and other immune-mediated diseases, today announced that its virtual-only annual meeting of shareholders will be held on tuesday, june 13, 2023, at 10:30 am et.
INKT Ratings Summary
INKT Quant Ranking